Stockscreener 앱 받기
3.49
11.15%
0.35
Adial Pharmaceuticals Inc (ADIL) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Operating Expenses |
2,499%
52.02
|
2.0015 | 1.8854 | 1.7641 | 1.8827 |
| Operating Income/Loss |
2,499%
-52.02
|
-2.0015 | -1.8854 | -1.7641 | -1.8827 |
| Nonoperating Income/Loss |
272.16%
0.036
|
-0.0209 | -0.1108 | -0.0296 | -0.0758 |
| Income/Loss From Equity Method Investments |
166.29%
-0.181
|
-0.068 | -0.1534 | -0.0769 | -0.0987 |
| Net Income/Loss |
2,471%
-51.99
|
-2.0224 | -1.9962 | -1.7937 | -1.9586 |
| Basic Average Shares |
237.33%
4.6217
|
1.3701 | -12.50 | 22.17 | - |
| Diluted Average Shares |
237.33%
4.6217
|
1.3701 | -12.50 | 22.17 | 10.62 |
| Basic Earnings Per Share |
660.14%
-11.25
|
-1.48 | -11.48 | -0.08 | -0.18 |
| Diluted Earnings Per Share |
660.14%
-11.25
|
-1.48 | -11.48 | -0.08 | -0.18 |
4.22%
자본화:
|
볼륨(24시간):